Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Studies with AM-251 support CB1 receptor antagonism in smoking cessation

Jan. 24, 2008

Fast track designation for Sabril in cocaine and methamphetamine dependence treatment

Jan. 23, 2008

Cleveland BioLabs' Protectan CBLB-502 not selected for defense contract award

Jan. 22, 2008

Evotec' EVT-302 for smoking cessation well tolerated in phase I study

Jan. 10, 2008

Studies examine activity of LY-686017 in alcoholism, social anxiety and IBS

Jan. 10, 2008

Bupropion ameliorates methamphetamine dependence in some patients

Dec. 28, 2007

Catalyst reports positive phase II trial results for vigabatrin for cocaine addiction

Dec. 11, 2007

HDAC5 function in nucleus accumbens altered by chronic cocaine and stress

Dec. 5, 2007

Low daily doses of rimonabant reduce responses to cannabis

Nov. 30, 2007

E.U. approves Merck Serono's Cyanokit for cyanide poisoning

Nov. 29, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...